Assoc. Director, Quality Management Systems
Kiniksa Pharmaceuticals is a commercial‑stage biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. With deep expertise in immunology and inflammation, Kiniksa is advancing a growing portfolio of approved and investigational medicines, anchored by its lead product, ARCALYST®, the first and only FDA‑approved therapy for recurrent pericarditis. Grounded in rigorous science and bold innovation, the company fosters a highly collaborative, patient‑first culture led by accomplished life sciences leaders. At Kiniksa, talented individuals are trusted and empowered to make a real impact—shaping the future of medicine while improving the lives of patients who need it most.
The Associate Director, Quality Management Systems (QMS) is responsible for the site's GxP quality systems, including Document Control, Records Management, and Exceptions Management (Deviations, CAPAs, Change Controls, and Investigations/OOS). Reporting to the Director, Quality
